T&L Co., Ltd. (KOSDAQ:340570)
30,850
+200 (0.65%)
Sep 2, 2026, 11:05 AM KST
T&L Co., Ltd. Revenue
T&L Co., Ltd. had revenue of 56.02B KRW in the quarter ending June 30, 2026, with 44.51% growth. This brings the company's revenue in the last twelve months to 175.16B, down -5.48% year-over-year. In the year 2025, T&L Co., Ltd. had annual revenue of 164.16B, down -6.14%.
Revenue (ttm)
175.16B
Revenue Growth
-5.48%
P/S Ratio
2.81
Revenue / Employee
723.80M
Employees
242
Market Cap
491.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 164.16B | -10.73B | -6.14% |
| Dec 31, 2024 | 174.89B | 59.43B | 51.47% |
| Dec 31, 2023 | 115.46B | 33.88B | 41.54% |
| Dec 31, 2022 | 81.58B | 9.68B | 13.47% |
| Dec 31, 2021 | 71.90B | 31.26B | 76.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 738.76B |
| Value Added Technology | 441.04B |
| i-SENS | 326.19B |
| InBody Co.,Ltd | 263.89B |
| Vieworks | 244.28B |
| WON TECH | 159.67B |
| BioNote | 126.41B |
| SEERS | 97.05B |